Physician profile
Colm Mccarthy
NPI 1982269205
$5,900.26
in general payments reported to CMS, 2019-2025
14 companies · $1,272 in 2025
The $1,272 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $551 · 2021: $1,147 · 2022: $1,610 · 2023: $1,204 · 2024: $116 · 2025: $1,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062 · Travel and Lodging: $1,056 · Education: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.20 |
| Travel and Lodging | $1,055.83 |
| Education | $474.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,346.22 | 2023-2025 | Oxford, Arcos, Oxford Partial Knee |
| Stryker Corporation | $1,653.96 | 2020-2024 | T2 Alpha |
| Kairos Surgical INC | $1,216.66 | 2022 | |
| Smith+Nephew, INC. | $277.37 | 2021-2024 | Pico, Renasys Touch |
| Innovation Technologies INC | $106.78 | 2022 | |
| Baudax Bio INC. | $63.65 | 2021-2022 | |
| Kerecis Limited | $60.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Davol INC. | $50.82 | 2023 | Arista Ah Flexitip |
| Heron Therapeutics, INC. | $24.71 | 2022 | |
| Bioventus LLC | $22.75 | 2022 | |
| Pacira Therapeutics, INC. | $22.07 | 2021 | |
| Si-Bone, INC. | $20.68 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.04 | 2022 | |
| Medical Device Business Services, INC. | $14.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colm Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.